Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Completed
Conditions studied: Trichomonas Vaginalis
In brief
The objective of this study is to obtain female first-catch urine, vaginal swab, endocervical swab, and cervical specimens collected in PreservCyt Solution ("PreservCyt Specimens") for testing with the APTIMA Trichomonas vaginalis (ATV) Assay. These specimens will be used to demonstrate assay performance on the PANTHER System is comparable to performance on the TIGRIS System.
Key facts
- Study ID
- NCT01427023
- Run by
- Gen-Probe, Incorporated
- People needed
- 532
- Starts
- 2012-08-01
- Expected to finish
- 2013-12-01
- Last updated by the study team
- 2014-02-06
Who can join
Age: 14 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Subject must be female and attend a participating clinic
- Subject must be at least 14 years of age at the time of enrollment and is currently sexually active (has had vaginal intercourse within the past 12 months)
- The subject and/or legally authorized representative is willing to undergo the informed consent process prior to study participation (a minor will need the documented consent of her parent or legal guardian, unless the site has an institutional review board (IRB)- approved waiver for parental consent for minors)
- In addition, the subject must meet at least one of the following criteria:
- Subject must demonstrate symptoms consistent with a suspected STD such as vaginal odor, vaginal discharge, vaginal/vulvar itching or irritation, pain/discomfort during sexual intercourse or urination, and/or lower abdominal discomfort
- Subject must be asymptomatic and known to be partners with, or a contact of, a person with a confirmed or suspected STD(s)
- Subject must be asymptomatic and undergoing screening evaluation for possible STDs
- Subject must be undergoing Pap screening
You may not qualify if…
- Subject took antibiotic medications within the last 14 days
- Subject already participated in the study
- Subject has a history of illness that the principal investigator (PI) or designee considers could interfere with or affect the conduct, results, and/or completion of the clinical trial
- Subject has a history of illness that the PI or designee considers could create an unacceptable risk to the subject if enrolled
Where it is running
- University of Alabama, Birmingham — Birmingham, Alabama, United States
- Wishard Hospital - Indiana University School of Medicine — Indianapolis, Indiana, United States
- Louisiana State University — New Orleans, Louisiana, United States
- New England Center for Clinical Research — Fall River, Massachusetts, United States
- University of North Carolina, Chapel Hill — Chapel Hill, North Carolina, United States
- Geneuity Clinical Research Services — Maryville, Tennessee, United States
- Planned Parenthood Gulf Coast — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.